MOST NOTEWORTHY: Chesapeake, Brookfield Asset Management and Nile Therapeutics were today’s noteworthy initiations:

• Jefferies initiated Chesapeake Energy Corp. (NYSE: CHK) with a Buy rating and $54 target and thinks the company can post group-leading biological growth in production and reserves by the next several years.
• Thomas Weisel assumed Brookfield Asset Management (NYSE: BAM) with a Market Weight rating citing slowing cash flow growth.
• Rodman & Renshaw is positive on Nile Therapeutics’ (OTC: NILT) lead compound, CD-NP, a chimeric natriuretic peptide with potential efficacy and safety enhancements that could
  permit broad use in acute heart failure setting. The firm started shares of Nile with a Market Outperform rating and $7 target.

OTHER INITIATIONS:

• Baird initiated Concur Tech (NASDAQ: CNQR) with a Neutral rating.
• RBC Capital initiated General Moly (AMEX: GMO) with a Sector Perform rating and $11 target.
• Wachovia (NYSE: WB) was reinstated at Goldman with a Neutral rating.

Original post by Eric Buscemi

credit report mortgage real estate college credit repair payday loans student loan consolidation credit insurance child support